Opinion/decision on a Paediatric investigation plan (PIP): Hetlioz, tasimelteon, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Nervous system disorders, PIP number: P/0329/2024

Opinion/decision on a Paediatric investigation plan (PIP): Shingrix, recombinant varicella zoster virus glycoprotein E, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infections and infestations, PIP number: P/0328/2024

Frequently asked questions about parallel distribution

Veterinary medicines European public assessment report (EPAR): Suvaxyn Circo, porcine circovirus vaccine (inactivated, recombinant), Status: Authorised

Veterinary medicines European public assessment report (EPAR): Suvaxyn Circo+MH RTU, porcine circovirus and porcine enzootic pneumonia vaccine (inactivated), Status: Authorised

Veterinary medicines European public assessment report (EPAR): Suiseng Diff/A, clostridioides difficile,clostridium perfringens vaccine, inactivated, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Stelfonta, tigilanol tiglate, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Sevohale (previously Sevocalm), sevoflurane, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Sedadex, dexmedetomidine, Status: Authorised

EMEA-002338-PIP01-18